Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-12-01T02:56:37.668Z Has data issue: false hasContentIssue false

Anxious Distress is Associated with Increased Immune Dysregulation in Patients with Major Depressive Disorder

Published online by Cambridge University Press:  23 March 2020

R. Gaspersz
Affiliation:
VUMC, Psychiatry, Amserdam, The Netherlands
F. Lamers
Affiliation:
VUMC, Psychiatry, Amserdam, The Netherlands
G. Wittenberg
Affiliation:
Janssen Research & Development- LLC, Neuroscience, Raritan New Jersey, USA
A. Beekman
Affiliation:
VUMC, Psychiatry, Amserdam, The Netherlands
A. van Hemert
Affiliation:
Leiden University Medical Center, Psychiatry, Leiden, The Netherlands
R. Schoevers
Affiliation:
University Medical Center Groningen, Psychiatry, Groningen, The Netherlands
B. Penninx
Affiliation:
VUMC, Psychiatry, Amserdam, The Netherlands

Abstract

Introduction

Although depression with anxious distress appears to be a clinically relevant subtype of Major Depressive Disorder (MDD), whether it involves specific pathophysiology remains unclear. Inflammation has been implicated, but not comprehensively studied. We examined within a large MDD sample whether anxious distress and related anxiety features are associated with differential basal inflammation and innate cytokine production capacity.

Methods

Data are from 1078 MDD patients from the Netherlands study of depression and anxiety. Besides the DSM-5 anxious distress specifier, we studied various dimensional anxiety scales (e.g. Inventory of Depressive Symptomatology anxiety arousal subscale [IDS-AA], Beck Anxiety Inventory [BAI], Mood and Anxiety Symptoms Questionnaire Anxious Arousal scale [MASQ-AA]). Basal inflammatory markers included C-reactive protein, interleukin (IL)-6 and tumor-necrosis factor (TNF)-α. Innate production capacity was assessed by 13 lipopolysaccharide (LPS)-stimulated inflammatory markers. Basal and LPS-stimulated inflammation index scores were created.

Results

Basal inflammation was not associated with anxious distress in MDD patients (anxious distress prevalence 54.3%), except for modest positive associations for IDS-AA and BAI scores. However, anxious distress was associated with higher LPS-stimulated levels (interferon-ɣ, IL-2, IL-6, monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, matrix metalloproteinase-2, TNF-α, TNF-β, LPS-stimulated index). Oher anxiety indicators (number of specifier items and anxiety diagnoses, IDS-AA, BAI, MASQ-AA) were also associated with increased innate production capacity.

Conclusions

Within a large MDD sample, the anxious distress specifier was associated with increased innate cytokine production capacity but not with basal inflammation. Results from dimensional anxiety indicators largely confirm these results. These findings provide new insight into the pathophysiology of anxious depression.

Type
e-Poster walk: Epidemiology and social psychiatry; intellectual disability
Copyright
Copyright © European Psychiatric Association 2017

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Submit a response

Comments

No Comments have been published for this article.